Gürdal YILMAZ, Savaş ÖZSU, İftihar KÖKSAL, Tevfik ÖZLÜ

Suitable Empiric Antibiotic Therapy Saves Life in Nosocomial Pneumonia Caused by Stenotrophomonas maltophilia

Stenotrophomonas maltophilia is a nosocomial pathogen of increasing importance. Empiric antibiotic therapy for S. maltophilia infection is difficult because the microorganism is resistant to a number of agents typically used for health care associated infections, thus potentially increasing mortality. This study investigates 23 nosocomial pneumonia cases caused by S. maltophilia, the antibacterial sensitivity of the bacterium and the effect on mortality of suitable empiric therapy. Materials and methods: Twenty-three patients with nosocomial pneumonia caused by S. maltophilia between January 2000 and December 2006 at the Karadeniz Technical University Hospital were retrospectively investigated. Results: Suitable empiric therapy was used with 12 patients (52.2%), but the therapies administered to the other 11 patients were inappropriate for S. maltophilia infection. Eight (72.7%) of the patients who were not given suitable empiric antibiotherapy died (P = 0.002). Conclusion: The appropriate empiric antibiotic was administered to only 12 of the patients. The mortality rate among those patients to whom appropriate empiric antibiotics were not administered was high, proving that suitable empiric therapy is vitally important. Due to the increase in mortality, it is essential to initiate appropriate empiric therapy by carefully evaluating the risk factors for S. maltophilia in nosocomial pneumonia and taking sputum and bronchoalveolar lavage specimens without delay.

Anahtar Kelimeler:

Key words: Stenotrophomonas maltophilia, nosocomial pneumonia, empiric antibiotic

Suitable Empiric Antibiotic Therapy Saves Life in Nosocomial Pneumonia Caused by Stenotrophomonas maltophilia

Keywords:

Key words: Stenotrophomonas maltophilia, nosocomial pneumonia, empiric antibiotic,

PDF

___

1. Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007; 28: 825-31.
2. Caylan R, Kaklikkaya N, Aydin K, Aydin F, Yilmaz G, Ozgumus B, et al. An epidemiological analysis of Stenotrophomonas maltophilia strains in a university hospital. Jpn J Infect Dis 2004; 57: 37-40.
3. Caylan R, Yilmaz G, Sucu N, Bayraktar O, Aydin K, Kaklikkaya N, et al. Nosocomial Stenotrophomonas maltophilia infections in a university hospital. Mikrobiyol Bul 2005; 39: 25-33.
4. Senol E. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen. J Hosp Infect 2004; 57: 1-7.
5. Teo WY, Chan MY, Lam CM, Chong CY. Skin manifestation of Stenotrophomonas maltophilia infection--a case report and review article. Ann Acad Med Singapore 2006; 35: 897-900.
6. Dignani MC, Grazziutti M, Anaissie E. Stenotrophomonas maltophilia infections. Semin Respir Crit Care Med 2003; 24: 89-98.
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections 1988. Am J Infect Control 1988; 16: 128-40.
8. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998; 11: 57-80.
9. Aydın K, Köksal İ, Kaygusuz S, Kaklıkkaya İ, Çaylan R, Özdemir R. Endocarditis caused by Stenotrophomonas maltophilia. Scand J Infect Dis 2000; 32: 427-30.
10. Caylan R, Aydın K, Köksal İ. Meningitis caused by Stenotrophomonas maltophilia. Annals of Saudi Medicine 2002; 22: 216-8.
11. German V, Tsimpoukas F, Goritsas C, Ferti A. Spondylodiscitis due to Stenotrophomonas maltophilia. Eur J Intern Med 2007; 18: 501-3.
12. Schaumann R, Stein K, Eckhardt C, Ackermann G, Rodloff AC. Infections caused by Stenotrophomonas maltophilia- A prospective study. Infection 2001; 29: 205-8.
13. Friedman N, Korman T, Fairley C, Franklin J, Spelman D. Bacteremia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect 2002; 45: 47-53.
14. Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000; 31: 705-11.
15. Gales AC, Jones RK, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999). Clin Infect Dis 2001; 32: 104-13.
16. Jones RN, Sader HS, Beach ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). Int J Antimicrob Agents 2003; 22: 551-6.
17. Fadda G, Spanu T, Ardito F, Taddei C, Santangelo R, Siddu A, et al. Antimicrobial resistance among non-fermentative Gramnegative bacilli isolated from the respiratory tracts of Italian inpatients: a 3-year surveillance study by the Italian Epidemiological Survey. Int J Antimicrob Agents 2004; 23: 254- 61.
18. Nicodemo AC, Araujo MR, Ruiz AS, Gales AC. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, E-test and agar dilution methods. J Antimicrob Chemother 2004; 53: 604-8.
19. Gopalakrishnan R, Hawley B, Czachor JS, Markert R, Bernstein J. Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: A study of 143 patients. Heart Lung 1999; 28: 134-41.
20. Maningo E, Watanakunakorn C. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect 1995; 31: 89-92.
21. Hanes SD, Demirkan K, Tolley E, Boucher BA, Croce MA, Wood GC, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis 2002; 35: 228-35.